Welcome to the e-CCO Library Archive!
Validation of the Portuguese version of a questionnaire for the assessment of healthcare quality from the point of view of a patient with inflammatory bowel disease (QUOTE-IBD)
D. Fernandes*, M.C. Nogueira, B.M. Gonçalves, A. Machado, R. Gonçalves, J.B. Soares
Hospital of Braga, Department of Gastrenterology, Braga, Portugal
Correlation of FDG PET scanning with clinical and laboratory markers of activity in patients with Crohn's disease
E. Russo1, S. Khan2, A. Brown3, N. Keat3, W. Hallett3, R. Janisch3, R. Gunn3, E. Rabiner3, P. Matthews1, T. Orchard1, 1Imperial College London, Medicine, London, United Kingdom, 2Imperial College Healthcare NHS Trust, Radiology, London, United Kingdom, 3Imanova, Imaging, London, United Kingdom
P. Katz1, D. Rex2, M. Epstein3, J. Masure4, R. Joseph5, 1Albert Einstein Healthcare Network, Philadelphia, United States, 2Indiana University School of Medicine, Indianapolis, United States, 3Digestive Disorders Associates, Annapolis, United States, 4Ferring International Center SA, Saint-Prez, Switzerland, 5Ferring Pharmaceuticals Inc, Parsippany, United States
Diagnostic delay in IBD: a comparison in the last thirty years, an Italian multicentric study
L. Cantoro*1, A. Di Sabatino2, C. Papi3, G. Margagnoni3, S. Ardizzone4, A. Massari4, P. Giuffrida2, R. Monterubbianesi5, A. Kohn5
1Azienda Ospedaliera San Camillo-Forlanini, Gastroenterology, Rome, Italy, 2Fondazione IRCCS Policlinico San Matteo, University of Pavia, First Department of Medicine, Pavia, Italy, 3A.O.San Filippo Neri, Gastroenterology and Hepatology Unit, Rome, Italy, 4Luigi Sacco University Hospital, Gastroenterology and IBD Unit, Milan, Italy, 5Azienda Ospedaliera San Camillo-Forlanini , Gastroenterology, Roma, Italy
Correlation between severity of endoscopic lesions and clinical activity in a cohort of Crohn's disease patients followed up for 5 years after ileo-colonic resection
S. Onali, E. Calabrese, C. Petruzziello, G. Condino, M. Ascolani, E. Lolli, F. Pallone, L. Biancone, Gastroenterology Unit, University of Rome Tor Vergata, Department of Systems Medicine, Rome, Italy
D. Rex1, P. Katz2, G. Bertiger3, J. Masure4, R. Joseph5, 1Indiana University School of Medicine, Indianapolis, United States, 2Albert Einstein Healthcare Network, Philadelphia, United States, 3Hillmont GI, Flourtown, United States, 4Ferring International Center SA, Saint-Prez, Switzerland, 5Ferring Pharmaceuticals Inc, Parsippany, United States
Fulminant hepatic failure requiring transplantation after initiation of infliximab therapy in Ulcerative Colitis
R.S. Parra*1, V. Foresto Machado1, M. Ribeiro Feitosa1, Ê. David Mente1, L. Naira Zambelli Ramalho2, 3, J. Joaquim Ribeiro da Rocha1, O. Féres1
1University of Sao Paulo, Surgery and Anatomy, Ribeirao Preto SP, Brazil, 2University of Sao Paulo, Pathology, Ribeirao Preto SP, Brazil, 3University of São Paulo, Pathology, Ribeirao Preto, Brazil
Conventional and contrast-enhanced ultrasound (CEUS) in the evaluation of Crohn's disease activity
L. Ballesteros, M. Calvo, M.P. Delgado, A.M. Martín, P. Martínez, B. Casis, G. Castellano, Hospital Universitario 12 de Octubre, Gastroenterology, Madrid, Spain
T. Ogawa1, Y. Ohda1, K. Nagase1, Y. Yokoyama1, K. Tozawa1, K. Hori1, S. Nakamura1, H. Miwa2, T. Matumoto1, 1Hyogo College of Medicine, Division of Lower Gastroenterology, Nishinomiya, Hyogo, Japan, 2Hyogo College of Medicine, Division of Upper Gastroenterology, Nishinomiya, Hyogo, Japan
De novo Inflammatory Bowel Disease following paediatric liver transplantation: A case series of three patients and world literature review
K. Nikaki*1, D.C. Wilson2, P. McKiernan3, C.H. Spray4
1Birmingham Children's Hospital NHS Foundation Trust, Paediatric Liver Unit, Birmingham, United Kingdom, 2Royal Hospital for Sick Children, Paediatric Gastroenterology and Nutrition Department , Edinburgh, United Kingdom, 3Birmingham Children's Hospital NHS Foundation Trust, Paediatric Liver Unit , Birmingham, United Kingdom, 4Bristol Royal Hospital for Children, Paediatric Gastroenterology Department, Bristol, United Kingdom
Risk Factors for De Novo IBD and Immunosuppressive Rx before and after De Novo IBD Diagnosis
| Case 1: Crohn’s disease | Case 2: Indeterminate Colitis | Case 3: Crohn’s disease | |
|---|---|---|---|
| CMV mismatch (donor / recipient) | -ve/-ve | +ve / -ve | -ve/-ve |
| CMV infection post LTx | No | No | No |
| Acute / Chronic Rejection | No / Yes | No / No | No / No |
| Biliary stasis | No | No | No |
| PMHx of Autoimmunity | No | No | No |
| FHx of Autoimmunity | No | No | No |
| Immunosuppression at presentation with de novo IBD | Tacrolimus, Prednisolone, MMF | Cyclosporine | Cyclosporine |
| Immunosuppression after diagnosis with de novo IBD | Tacrolimus, Prednisolone, AZA | MMF, Prednisolone | MMF, Prednisolone |
| Other IBD Tx following diagnosis | Infliximab | Mesalazine | Mesalazine |
Contrast enhanced ultrasound as a point-of-care technique in complicated Crohn's disease patients
E. Calabrese, F. Zorzi, E. Stasi, E. Lolli, S. Onali, P. Scarozza, G. Condino, C. Petruzziello, L. Biancone, F. Pallone, Gastroenterology Unit, University of Rome Tor Vergata, Department of Systems Medicine, Rome, Italy